Insights into Basic Mechanisms of Hepatocarcinogenesis
Nov
13
2023
Republic Ballroom
-
Sheraton Boston Hotel
11:00
AM
- 12:30 PM EST
Speakers
Description
Abstracts
- A POSITIVE FEEDBACK BETWEEN CHOLESTEROL SYNTHESIS AND THE PENTOSE PHOSPHATE PATHWAY RATHER THAN GLYCOLYSIS PROMOTES HEPATOCELLULAR CARCINOMA
- PHARMACOLOGICAL INHIBITION OF DISCOIDIN DOMAIN RECEPTOR TYROSINE KINASE 1 (DDR1) FOR HCC CHEMOPREVENTION AFTER HCV CURE
- PSMP INHIBITS HCC PROGRESSION BY REGULATING THE POLARIZATION OF TUMOR-ASSOCIATED MACROPHAGES THROUGH THE PI3K/AKT PATHWAY
- EZURPIMTROSTAT AUTOPHAGY BLOCKER, A PALMITOYL-PROTEIN THIOESTERASE 1 (PPT1) INHIBITOR, AND ATEZOLIZUMAB/BEVACIZUMAB TRIPLE COMBINATION REGIMEN ENHANCES ANTITUMOR EFFICACY IN HEPATOCELLULAR CARCINOMA
- HUMAN-CORRELATED GENETIC HCC MODELS IDENTIFY COMBINATION THERAPY FOR PRECISION MEDICINE
- SLC1A5 REGULATES LIPID METABOLISM AND FORMS AN IMMUNOSUPPRESSIVE TME IN HCC